First Header Logo Second Header Logo

DAB389EGF fusion protein therapy of refractory glioblastoma multiforme.

Cohen KA, Liu T, Bissonette R, Puri RK, Frankel AE. DAB389EGF fusion protein therapy of refractory glioblastoma multiforme. Curr Pharm Biotechnol. 2003 Feb; 4(1):39-49.

View in: PubMed